AONC Stock Analysis
AO
Uncovered
American Oncology Network Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
American Oncology Network, Inc. engages in the provision of community-based oncology management. The company is headquartered in Fort Myers, Florida and currently employs 1,525 full-time employees. The company went IPO on 2021-03-10. The firm has offered a progressive model of physician-led, community-based oncology management. Its business is focused on caring for adult and senior populations with medical oncology and related care needs, including members of Medicare Advantage (MA) plan run by private insurance companies on behalf of the Centers for Medicare and Medicaid Services, or CMS, as well as traditional Fee-For-Service (FFS) Medicare, Medicaid, other government healthcare programs and commercial insurance populations. The company provides patients with a variety of services, including in-house professional and technical pathology providing complete pathology reports; in-house specialty pharmacy with patient education, financial assistance and 24/7 patient assistance, and care management support services including nutrition guidance. The firm's network represents more than 220 providers practicing across 20 states.